MRKR — Marker Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1094038 ·
Last close
$0.84
Market Cap
$13.95M
52W High
$2.46
52W Low
$0.81
ADV30
169,847
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 0 | — | -1,936,257 | -1,844,472 | 12,499,291 | 9,039,785 | 1,996,412 |
| Jun 2026 | 0 | — | -1,938,787 | -1,826,229 | 14,585,485 | 11,331,023 | 2,420,021 |
| Mar 2026 | 0 | — | -3,320,844 | -3,179,278 | 17,434,008 | 14,915,519 | 3,638,050 |
| Dec 2025 | 0 | — | -1,883,994 | -1,703,210 | 19,070,997 | 16,068,048 | 2,274,183 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-9,756,497
Investing CF
—
Financing CF
$9,863,883
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.66
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-464,186,305
Inventory
—
Receivables
$1,619,477
ST Investments
—
EBIT TTM
$-9,280,351
Pretax Income TTM
$-8,722,535
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,546,669
EBITDA
—
Free Cash Flow
$-6,227,035
Enterprise Value
$7,843,073
Total Cash
$11,331,023
Total Debt
$0
Shares Out
16,673,127
Trailing EPS
$-0.38
Book Value
$0.73
ROE
-76.9%
ROA
-40.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -12,437,291 | -12,163,620 | 19,070,997 | 2,274,183 | 16,796,814 | -12,014,081 |
| Dec 2024 | 0 | -11,118,372 | -10,731,315 | 22,022,860 | 3,464,454 | 18,558,406 | -10,910,324 |
| Dec 2023 | 3,311,133 | -11,270,245 | -8,236,814 | 17,127,391 | 3,074,848 | 14,052,543 | -16,439,961 |
| Dec 2022 | 0 | -19,791,004 | -29,930,694 | 34,422,184 | 14,821,147 | 19,601,037 | -26,972,153 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$2,581,828
NetIncome TTM
$-8,707,379
OpCashFlow TTM
—
Assets (Latest)
$14,585,485
Forward EPS
$-0.53
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INTI | Inhibitor Therapeutics, Inc. | $13.98M | $0.08 | — |
| ACTU | ACTUATE THERAPEUTICS, INC. | $13.84M | $0.25 | — |
| CTXR | Citius Pharmaceuticals, Inc. | $14.24M | $0.52 | — |
| MCRB | Seres Therapeutics, Inc. | $14.37M | $1.41 | — |
| SYBX | SYNLOGIC, INC. | $13.47M | $1.10 | — |
News headlines (Yahoo Finance, 1h cache)
MARKER THERAPEUTICS, INC. (MRKR) Reports Q3 Loss, Lags Revenue Estimates
2026-11-16 22:50 · Yahoo
Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer
2026-10-19 11:00 · Yahoo
All You Need to Know About MARKER THERAPEUTICS (MRKR) Rating Upgrade to Strong Buy
2026-10-16 15:00 · Yahoo
New Strong Buy Stocks for October 16th
2026-10-16 07:04 · Yahoo
Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies
2026-09-22 12:00 · Yahoo
High Growth Tech Stocks To Watch In US June 2026
2026-06-03 11:38 · Yahoo
Rigel Pharmaceuticals (RIGL) Misses Q3 Earnings Estimates
2026-11-06 00:00 · Yahoo
Aurinia Pharmaceuticals (AUPH) Surpasses Q2 Earnings Estimates
2026-08-06 13:50 · Yahoo
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
2026-06-26 08:59 · Yahoo
US High Growth Tech Stocks with Promising Potential
2026-06-05 11:38 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.